Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasm, Experimental”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04539574
What this trial is testing

An Investigational Scan (7T MRI) for the Imaging of Central Nervous System Tumors

Who this might be right for
Central Nervous System NeoplasmGliomaMetastatic Malignant Neoplasm in the Central Nervous System+1 more
M.D. Anderson Cancer Center 50
Early research (Phase 1)Looking for participantsNCT07361562
What this trial is testing

A Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor, AdultERBB2 Altered Breast CancerERBB2 Gene Amplification+3 more
Cogent Biosciences, Inc. 100
Early research (Phase 1)Looking for participantsNCT07222267
What this trial is testing

An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors

Who this might be right for
Breast CancerAdvanced Solid Tumor
BeOne Medicines 86
Not applicableUnknownNCT06360692
What this trial is testing

Impact of Nipple Micropigmentation in Mastectomized Women

Who this might be right for
Body ImageFemale Sexual FunctionSelf Esteem+1 more
Cardenal Herrera University 30
Early research (Phase 1)Ended earlyNCT03444753
What this trial is testing

An Investigational Immunotherapy Study of BMS-986299 Alone and in Combination With Nivolumab and Ipilimumab in Participants With Solid Cancers That Have Spread or Cannot be Removed

Who this might be right for
Advanced Cancer
Bristol-Myers Squibb 82
Testing effectiveness (Phase 2)Looking for participantsNCT07111520
What this trial is testing

A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung Cancer
BioNTech SE 880
Not applicableStudy completedNCT06702982
What this trial is testing

Virtual Support, Real Impact: Effectiveness of Tele-nursing in Alleviating Chemotherapy Symptoms Among Cancer Patients

Who this might be right for
CancerChemotherapy EffectQuality of Life (QOL)
Helwan University 74
Testing effectiveness (Phase 2)Ended earlyNCT03363776
What this trial is testing

An Investigational Immuno-Therapy Study of Experimental Medication BMS-986277 Given Alone and in Combination With Nivolumab in Epithelial Cancers

Who this might be right for
Cancer
Bristol-Myers Squibb 10
Testing effectiveness (Phase 2)Looking for participantsNCT06445972
What this trial is testing

Substudy 06D: Combination Therapies in Second Line (2L) Gastroesophageal Adenocarcinoma (MK-3475-06D/Keymaker-U06)

Who this might be right for
Gastroesophageal JunctionGastroesophageal AdenocarcinomaEsophageal Neoplasms+1 more
Merck Sharp & Dohme LLC 210
Testing effectiveness (Phase 2)Looking for participantsNCT06750185
What this trial is testing

Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
BioNTech SE 248
Testing effectiveness (Phase 2)Study completedNCT03543813
What this trial is testing

PROCLAIM-CX-2029: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2029 for Patients With Solid Tumors or DLBCL

Who this might be right for
Solid Tumor, AdultHead and Neck CancerNon Small Cell Lung Cancer+2 more
CytomX Therapeutics 133
Early research (Phase 1)Study completedNCT01486329
What this trial is testing

VXM01 Phase I Dose Escalation Study in Patients With Locally Advanced, Inoperable and Stage IV Pancreatic Cancer

Who this might be right for
Stage IV Pancreatic Cancer
Vaximm GmbH 72
Very early researchActive Not RecruitingNCT05245786
What this trial is testing

An Investigational Scan (64Cu-Labeled M5A Antibody) in Combination With SOC Chemotherapy and Radiotherapy in Locally Advanced Rectal Cancer

Who this might be right for
Locally Advanced Rectal CarcinomaStage III Rectal Cancer AJCC v8Stage IIIA Rectal Cancer AJCC v8+2 more
City of Hope Medical Center 14
Testing effectiveness (Phase 2)Looking for participantsNCT07079631
What this trial is testing

A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment Pumitamig (BNT327) and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
BioNTech SE 482
Not applicableStudy completedNCT03213951
What this trial is testing

Ex-vivo Investigation of Beta Probe for Prostate Cancer Resection and Evaluation of PSMA-PET for Diagnosis of Intraprostatic Lesions

Who this might be right for
Prostate Cancer
Indiana University 28
Early research (Phase 1)Study completedNCT00055380
What this trial is testing

Chemical and Genetic Effects of the Experimental Anti-Cancer Drugs in Cheek Cells in Cancer Patients

Who this might be right for
Cancer
National Institute of Dental and Craniofacial Research (NIDCR) 120
Testing effectiveness (Phase 2)Active Not RecruitingNCT04575961
What this trial is testing

Study of Pembrolizumab Combination With Chemotherapy in Platinum-sensitive Recurrent Low-grade Serous Ovarian Cancer

Who this might be right for
Ovarian CancerLow Grade Serous CarcinomaPrimary Peritoneal Carcinoma+1 more
North Eastern German Society of Gynaecological Oncology 33
Testing effectiveness (Phase 2)Study completedNCT04165096
What this trial is testing

KEYMAKER-U01 Substudy 3: Efficacy and Safety Study of Pembrolizumab (MK-3475) When Used With Investigational Agents in Participants With Advanced Non-small Cell Lung Cancer (NSCLC), Previously Treated With Anti-programmed Cell Death Receptor Ligand 1 (PD-L1) Therapy (MK-3475-01C/KEYMAKER-U01C)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Merck Sharp & Dohme LLC 128
Early research (Phase 1)Study completedNCT00343005
What this trial is testing

Experimental Vaccine for Malaria in Adults in Mali

Who this might be right for
Plasmodium Falciparum Malaria
National Institute of Allergy and Infectious Diseases (NIAID) 54
Not applicableStudy completedNCT03818230
What this trial is testing

An Evaluation of the Psychological Impact of Early Phase Clinical Trials in Cancer Patients.

Who this might be right for
CancerDepressionAnxiety+2 more
University of Manchester 64
Next Page